Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo.
about
Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?p70S6 kinase is a critical node that integrates HER-family and PI3 kinase signaling networks.High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression.Minireview: Challenges and opportunities in development of PPAR agonistsMolecular mechanisms of fenofibrate-induced metabolic catastrophe and glioblastoma cell death.Medicinal Chemistry and Actions of Dual and Pan PPAR Modulators.New and emerging strategies for reducing cardiometabolic risk factors.PPARgamma and MEK Interactions in CancerPharmacogenetics of the PPAR genes and cardiovascular disease.Rat Urinary Bladder Carcinogenesis by Dual-Acting PPARalpha + gamma AgonistsSession 2: Personalised nutrition. Transcriptomic signatures that have identified key features of metabolic syndrome.Role of cytokines and chemokines in alcohol-induced tumor promotion.Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies.Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Critical analysis of carcinogenicity study outcomes. Relationship with pharmacological properties.Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway.Fenofibrate-induced nuclear translocation of FoxO3A triggers Bim-mediated apoptosis in glioblastoma cells in vitro.PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments.Increase in weight induced by muraglitazar, a dual PPARalpha/gamma agonist, in db/db mice: adipogenesis/or oedema?PPAR alpha and PPAR gamma coactivation rapidly induces Egr-1 in the nuclei of the dorsal and ventral urinary bladder and kidney pelvis urothelium of rats.Urothelial carcinogenesis in the urinary bladder of rats treated with naveglitazar, a gamma-dominant PPAR alpha/gamma agonist: lack of evidence for urolithiasis as an inciting event.Trans-species comparison of PPAR and RXR expression by rat and human urothelial tissues.Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of action.
P2860
Q24564203-58667177-4C87-41D8-A054-E186A10BFCC5Q30371561-EE152168-8A4F-4356-A898-C011A957C11BQ33514114-D61A2E51-407B-4785-B693-B4DCBD64B14BQ33631921-2F5C559A-0329-4C39-9E64-C667E83DD691Q34968487-E16C2CC3-1032-4067-865F-BD30976E3DF1Q35216684-9ECBCC52-92CF-40DC-90F1-4787BED0FA19Q36459419-BB65B841-34C7-48BC-917F-A124D127BD6FQ36737285-65058477-9C85-42EF-9CAC-55181ECB8E5FQ37012017-2C1A098E-5B69-4435-9071-0BCD8D319412Q37077098-06F96847-62B9-4B7D-B69D-ADEE349BFF2CQ37291401-D98D1E16-F269-4EBA-89CE-AC040F0D1C46Q37718820-394D0914-C7BD-4456-A8A3-D63C6A126CAEQ38061184-550D9F4C-AB6B-4A85-950C-7BB2474D2EAAQ38222834-9B4D667B-719C-487A-B798-29FE93D86ED7Q38641190-A493D5BF-D879-4207-9E5B-891EB69D3274Q38818082-56CB1135-772C-4F65-99A9-3F652435AE77Q39239818-48F1965A-EA5D-4F6C-B688-FDF3792B155EQ39325469-175BEEDA-72AF-41D3-82DF-1828D4113428Q41677812-755CA963-6558-4F57-BBBB-E53817369AB2Q42797804-D8263D8D-3834-4191-99D6-F39F749FC73AQ43222810-1DB06F65-AF7E-4063-B100-D4246AE8FE3EQ46599209-75295A50-F174-4AA8-902B-794C5E6DAD89Q53321831-3A977A7E-C3DA-4DCE-A13A-DED5104BFF28Q53338744-577B602C-EB17-4A91-9D58-D5399C61AE80
P2860
Biomarkers for early effects of carcinogenic dual-acting PPAR agonists in rat urinary bladder urothelium in vivo.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Biomarkers for early effects o ...... ry bladder urothelium in vivo.
@en
Biomarkers for early effects o ...... ry bladder urothelium in vivo.
@nl
type
label
Biomarkers for early effects o ...... ry bladder urothelium in vivo.
@en
Biomarkers for early effects o ...... ry bladder urothelium in vivo.
@nl
prefLabel
Biomarkers for early effects o ...... ry bladder urothelium in vivo.
@en
Biomarkers for early effects o ...... ry bladder urothelium in vivo.
@nl
P2093
P2860
P1433
P1476
Biomarkers for early effects o ...... ry bladder urothelium in vivo.
@en
P2093
Nielsen HS
Oleksiewicz MB
Storgaard T
P2860
P304
P356
10.1080/13547500500218682
P577
2005-07-01T00:00:00Z